A new biomarker that predicts ventricular arrhythmia in patients with ischemic dilated cardiomyopathy: Galectin-3

McMurray, 2000, Epidemiology, etiology, and prognosis of heart failure, Heart, 83, 596, 10.1136/heart.83.5.596 Kannel, 1994, Changing epidemiological features of cardiac failure, Br Heart J, 72, 3, 10.1136/hrt.72.2_Suppl.S3 Stevenson, 1995, Ventricular arrhythmias in heart failure, 848 Stevenson, 1997, Exploring postinfarction reentrant ventricular tachycardia with entrainment mapping, J Am Coll Cardiol, 29, 1180, 10.1016/S0735-1097(97)00065-X Bakker, 1993, Slow conduction in the infarcted human heart. ‘Zigzag’ course of activation, Circulation, 88, 915, 10.1161/01.CIR.88.3.915 Takarada, 1990, Analysis of ventricular arrhythmias in patients with dilated cardiomyopathy – relationship between the effects of antiarrhythmic agents and severity of myocardial lesions, Jpn Circ J, 54, 260, 10.1253/jcj.54.260 Assomull, 2006, Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy, J Am Coll Cardiol, 48, 1977, 10.1016/j.jacc.2006.07.049 Wu, 2008, Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy, J Am Coll Cardiol, 24, 2414, 10.1016/j.jacc.2008.03.018 Yu, 2013, Genetic and pharmacological inhibition of galectin-3 prevents cardiac remodeling by interfering with myocardial fibrogenesis, Circ Heart Fail, 6, 107, 10.1161/CIRCHEARTFAILURE.112.971168 Calvier, 2015, The impact of galectin-3 inhibition on aldosterone-induced cardiac and renal injuries, JACC Heart Fail, 3, 59, 10.1016/j.jchf.2014.08.002 Lok, 2013, Galectin-3 is an independent marker for ventricular remodeling and mortality in patients with chronic heart failure, Clin Res Cardiol, 102, 103, 10.1007/s00392-012-0500-y Moss, 2004, Automatic Defibrillator Implantation Trial-II (MADIT-II) Research Group. Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator, Circulation, 21, 3760, 10.1161/01.CIR.0000150390.04704.B7 Stecker, 2006, Population-based analysis of sudden cardiac death with and without left ventricular systolic dysfunction: two-year findings from the Oregon Sudden Unexpected Death Study, J Am Coll Cardiol, 21, 1161, 10.1016/j.jacc.2005.11.045 Bolick, 1986, Quantitative analysis of myocardial infarct structure in patients with ventricular tachycardia, Circulation, 74, 1266, 10.1161/01.CIR.74.6.1266 Takahashi, 2004, Optical mapping of the functional reentrant circuit of ventricular tachycardia in acute myocardial infarction, Heart Rhythm, 1, 451, 10.1016/j.hrthm.2004.05.005 Schmidt, 2007, Infarct tissue heterogeneity by magnetic resonance imaging identifies enhanced cardiac arrhythmia susceptibility in patients with left ventricular dysfunction, Circulation, 115, 2006, 10.1161/CIRCULATIONAHA.106.653568 Scott, 2011, The extent of left ventricular scar quantified by late gadolinium enhancement MRI is associated with spontaneous ventricular arrhythmias in patients with coronary artery disease and implantable cardioverter-defibrillators, Circ Arrhythm Electrophysiol, 4, 324, 10.1161/CIRCEP.110.959544 de Haan, 2011, Scar size and characteristics assessed by CMR predict ventricular arrhythmias in ischaemic cardiomyopathy: comparison of previously validated models, Heart, 97, 1951, 10.1136/heartjnl-2011-300060 Gao, 2012, Prediction of arrhythmic events in ischemic and dilated cardiomyopathy patients referred for implantable cardiac defibrillator: evaluation of multiple scar quantification measures for late gadolinium enhancement magnetic resonance imaging, Circ Cardiovasc Imaging, 5, 448, 10.1161/CIRCIMAGING.111.971549 Sharma, 2004, Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction, Circulation, 110, 3121, 10.1161/01.CIR.0000147181.65298.4D Sharma, 2008, Novel anti-inflammatory mechanisms of N-Acetyl-Ser-Asp-Lys-Pro in hypertension-induced target organ damage, Am J Physiol Heart Circ Physiol, 294, H1226, 10.1152/ajpheart.00305.2007 Milting, 2008, Plasma biomarkers of myocardial fibrosis and remodeling in terminal heart failure patients supported by mechanical circulatory support devices, J Heart Lung Transplant, 27, 589, 10.1016/j.healun.2008.02.018 Francia, 2014, Osteopontin and galectin-3 predict the risk of ventricular tachycardia and fibrillation in heart failure patients with implantable defibrillators, J Cardiovasc Electrophysiol, 25, 609, 10.1111/jce.12364